Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-213-5 | CAS number: 947753-66-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 147 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 6
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 42 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 24
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
The subject chemical is currently not listed as a harmful substance in the Annex I of the EU Dangerous Substance Directive 67/548/EEC or in Annex VI to EC Regulation 1272/2008. It is not a Category 1 or 2 mutagen, carcinogen, or reproductive hazard; thus, DNEL/DMEL values for these endpoints were not derived. There is no published IOEL (Indicative Occupational Exposure Limit) value or other relevant exposure limit value available for this material.
Toxicology Summary
Acute toxicity
The acute oral and dermal toxicities of the surrogate chemical, undecenyl methoxycrylene, were low with LD50 values >2000 mg/kg bw.
Irritation
The subject chemical was not a skin irritant in humans at concentrations of up to 20% in an HRIPT study. The surrogate material, undecenyl methoxycrylene, was negative for skin sensitization when tested in vitro in the Episkin reconstituted human epidermis study. The subject chemical failed to produce an irritant response in vitro in the HET-CAM test utilizing hen's egg chorioallantoic membranes. The surrogate material, undecenyl methoxycrylene, was negative when tested in the SkinEthic in vitro test with reconstituted human corneal epithelial cells. The surrogate material produced a maximum group mean score of 11.0 in rabbits based on the Kay and Colandra classification scheme indicating minimal eye irritation potential.
Sensitization
The subject chemical was negative when tested in 56 human subjects in a HRIPT study. The surrogate chemical, undecenyl methoxycrylene, was negative when tested in the mouse local lymph node assay. The respiratory tract sensitization potential of the subject chemical is presumed to be low.
Repeated dose toxicity
The surrogate chemical, undecenyl methoxycrylene, was administered by oral gavage for a period of 42 -days for male rats and up to eight weeks for female rats at dose levels of 0, 100, 300 or 1000 mg/kg bw/day. Only minimal effects were observed in the liver and thyroid glands and were considered adaptive in nature and not to represent a significant systemic toxicity. The NOAEL in this study was reported as 1000 mg/kg bw/day. This latter value was used to derive long-term systemic DNEL values.
Genetic toxicity
The subject chemical was negative in two Ames bacterial mutagenicity assays at maximum plate incorporation levels of 5000 micrograms/plate. It was also negative for mutagenicity in an in vitro L5178Y T/K +- Mouse Lymphoma assay and an in vitro chromosomal aberration study using cultured human lymphocytes. The in vivo genetic toxicity of the subject chemical has not been determined.
Reproductive and developmental toxicity
The surrogate chemical, undecenyl methoxycrylene, failed to produce any reproductive or developmental toxicity when administered to rats by gavage at dose levels up to 1000 mg/kg bw/day. The NOAEL for reproductive effects was 1000 mg/kg bw/day.
DNEL Derivations
Mode of action considerations
For the critical study selected, a threshold mode of action was assumed.
Modification of the relevant dose descriptors to the correct starting point
In the case of worker exposures, the oral route of exposure was not considered. For potential dermal and inhalation exposures, route-to-route extrapolations from the oral NOAEL value were performed (see Guidance Document, Chapter R.8, Appendix R.8 -2). A first-pass effect was discounted for the purposes of these calculations.
Dermal:
Due to a lack of dermal absorption data for the subject chemical, complete absorption of the test material by both the oral and dermal routes was assumed. Thus, dermal exposure to the same amount of the test material would produce an equivalent internal dose. Differences in metabolism, distribution and elimination were not considered and thus no further corrections were applied (see Guidance Document, Section R.8.4.2, page 25). Thus the corrected dose descriptor for the worker is 1000 mg/kg bw/day.
Inhalation:
In the case of worker exposures, a 50% absorption of the test material by the oral versus the inhalation route was assumed (see Guidance Document, Chapter R.8, Appendix R.8.4.2, page 25). The rat repeated-dose oral NOAEL value was divided by 0.38 m3/kg bw to yield an equivalent air concentration for an 8 -hour exposure (see Guidance Document, Chapter R.8, Example R.8 -2, page 65). This value was further corrected to account for increased metabolic rate (and inhalation volume) in the case of light work versus basal metabolism (multiplicative factor of 6.7 m3/10 m3, or 0.67).
(NOAELoralX 0.50) / 0.38 m3/kg bwt = 1316 mg/m3
1316 mg/m3X 0.67 = 882 mg/m3= NOAELinh, corr
Application of assessment factors
Dermal:
An AF of 4 was applied to the corrected dose descriptor for dermal long-term (repeated dose) systemic effects in workers (interspecies differences, allometric scaling). In addition, an AF of 2 (subchronic to chronic) and an intraspecies (sensitive worker) AF of 3 were applied. The overall AF obtained was 24.
Inhalation:
Allometric scaling was already performed in the previous step (corrected dose descriptor) and no further factors were applied. In the case of worker exposure, an AF of 2 (subchronic to chronic) and an AF value of 3 (intraspecies, sensitive worker) was assigned to give an overall AF of 6.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 43.5 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 25 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 40
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 25 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 40
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
DNEL Derivations / Long-Term Systemic
Mode of action considerations
For the critical study selected, a threshold mode of action was assumed.
Modification of the relevant dose descriptors to the correct starting point
In the case of exposures of the general population, route-to-route extrapolations from the oral NOAEL value were performed for oral, dermal and inhalation (see Guidance Document, Chapter R.8, Appendix R.8 -2). A first-pass effect was discounted for the purposes of these calculations.
Oral:
Complete absorption of the subject chemical by the oral route was assumed. The corrected dose descriptor for the general population is 1000 mg/kg bw/day.
Dermal:
Due to a lack of dermal absorption data for the subject chemical, complete absorption of the test material by the dermal route was assumed. Differences in metabolism, distribution and elimination were not considered and thus no further corrections were applied (see Guidance Document, Section R.8.4.2, page 25). Thus the corrected dose descriptor for the general population is 1000 mg/kg bw/day.
Inhalation:
In the case of exposures of the general population, a 50% absorption of the test material by the oral versus the inhalation route was assumed (see Guidance Document, Chapter R.8, Appendix R.8.4.2, page 25). The rat repeated-dose oral NOAEL value was divided by 1.15 m3/kg bw to yield an equivalent air concentration for a continuous exposure (see Guidance Document, Chapter R.8, Example R.8 -2, page 64). This value was not further corrected.
(NOAELoralX 0.50) / 1.15 m3/kg bwt = 435 mg/m3
= NOAELinh, corr
Application of assessment factors
Oral:
An AF of 4 was applied to the corrected dose descriptor for oral long-term (repeated dose) systemic effects in the general population (interspecies differences, allometric scaling). In addition, an AF of 2 (subchronic to chronic) and an intraspecies (sensitive worker) AF of 5 were applied. The overall AF obtained was 40.
Dermal:
An AF of 4 was applied to the corrected dose descriptor for oral long-term (repeated dose) systemic effects in the general population (interspecies differences, allometric scaling). In addition, an AF of 2 (subchronic to chronic) and an intraspecies (sensitive person) AF of 5 were applied. The overall AF obtained was 40.
Inhalation:
Allometric scaling was already performed in the previous step (corrected dose descriptor) and no further factors were applied. In the case of worker exposure, an AF of 2 (subchronic to chronic) and an AF value of 5 (intraspecies, sensitive person) was assigned to give an overall AF of 10.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.